Give Hope Blog

colorectal cancer screening

Certain colorectal patients may benefit from immunotherapy

September 16, 2019 | Zen Vuong

People with colon and rectal tumors prone to “immune overdrive” don’t do well if they concurrently have an immune-suppressive tumor microenvironment, City of Hope researchers say.

Continue Reading

cancer cell

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Fakih KRAS Cell Mutation Small | City of Hope

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Quiana Godinez

New Immunotherapy for Colon Cancer Answers a Patient's Prayer

December 24, 2018 | Maxine Nunes

After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.

Continue Reading

Breakthroughs - ASCO

City of Hope Physicians and Scientists Present Trailblazing Research at Annual ASCO Meeting

June 2, 2017 | Letisia Marquez

City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.

Continue Reading

Back To Top